Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2024 AAAAI Annual Meeting
Stock Information for Cogent Biosciences Inc.
Loading
Please wait while we load your information from QuoteMedia.